EAPC pain guidelines

Guidelines development has been one action of the EAPC research network since its beginning. The European Association for Palliative Care (EAPC) Research Network published its first guidelines on the use of morphine and alternative opioids in cancer pain in 1996 and published an update in 2001. Subsequently, further work was performed to strengthen the scope of the EAPC recommendations by the application of rigorous, evidence-based methodology. This involved a number of collaborating groups who were assigned different topics which were identified by consensus as relevant and published as 12 systematic reviews in one monographic issue of Palliative Medicine. These results were summarized in the EAPC opioid evidence-based recommendations published in 2012 in Lancet Oncology. Since then the pain guidelines development group coordinated by Augusto Caraceni, Marie Fallon and Stein Kaasa undertook the commitment of revising and updating the 2012 guidelines and enlarging their scope from opioids to cancer pain management in general. Literature reviews on previously published topics have been updated, and reviews on new topics were performed.

The updated guidelines will be published 2017/2018.

 

EAPC PAIN GUIDELINES LIST OF TOPICS

  1. PAIN ASSESSMENT AND CLASSIFICATION
  2. OPIOID OF FIRST CHOICE
  3. TITRATION
  4. ALTERNATIVE ROUTES
  5. ROTATION
  6. EQUIANALGESIC RATIOS
  7. METHADONE
  8. TRANSDERMAL OPIOIDS (FENTANYL AND BUPRENORPHINE)
  9. TAPENTADOL
  10. OXYCODONE/NALOXONE
  11. INCIDENT PAIN
  12. KETAMINE
  13. DRUGS IN NEUROPATHIC PAIN
  14. NSAIDS/PARACETAMOL + WHO STEP III OPIOIDS
  15. WHO STEP I DRUGS
  16. WHO STEP II DRUGS
  17. WHO STEP II VS WHO STEP III
  18. GASTROINTESTINAL SIDE EFFECTS MANAGEMENT (nausea and vomiting)
  19. GASTROINTESTINAL SIDE EFFECTS MANAGEMENT (constipation)
  20. CENTRAL SIDE EFFECTS MANAGEMENT
  21. LIVER FAILURE
  22. RENAL FAILURE
  23. SPINAL OPIOIDS
  24. RADIOTHERAPY
  25. BISPHOSPHONATES
  26. CORTICOSTEROIDS
  27. INVASIVE ANALGESIC INTERVENTION
  28. DRUG INTERACTIONS
Thu, 28 Sep 2017 16:31:17 +0200